Assessment of Memory Impairment in Early Diagnosis of Alzheimer’s Disease-Reference-Cited by-同舟云学术

Assessment of Memory Impairment in Early Diagnosis of Alzheimer’s Disease

Published:2019-12-06 Issue:11 Volume:16 Page:975-985
ISSN:1567-2050
Container-title:Current Alzheimer Research
language:en
Short-container-title:CAR

Author:

Vyhnálek Martin¹,Marková Hana¹,Laczó Jan¹,De Beni Rossana²,Di Nuovo Santo³

Affiliation:

1. Memory Clinic, Department of Neurology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic

2. Department of Psychology, University of Padua, Padua, Italy

3. Department of Education, University of Catania, Catania, Italy

Abstract

Memory impairment has been considered as one of the earliest clinical hallmarks of Alzheimer’s disease. This paper summarizes recent progress in the assessment of memory impairment in predementia stages. New promising approaches of memory assessment include evaluation of longitudinal cognitive changes, assessment of long-term memory loss, evaluation of subjective cognitive concerns and testing of other memory modalities, such as spatial memory. In addition, we describe new challenging memory tests based on memory binding paradigms that have been recently developed and are currently being validated.

Funder

European Regional Development Fund

Ministry of Health of the Czech Republic

MH CZ - DRO

National Program of Sustainability II

Charles University

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Neurology,Neurology

Reference135 articles.

1. Albert M.S.; DeKosky S.T.; Dickson D.; Dubois B.; Feldman H.H.; Fox N.C.; The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging and Alzheimer’s Association workgroup. Alzheimers Dement (2011),7,270-279

2. Gainotti G.; Quaranta D.; Vita M.G.; Marra C.; Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer’s disease. J Alzheimers Dis (2014),38(3),481-495

3. Sperling R.; Aisen P.; Beckett L.; Bennett D.; Craft S.; Fagan A.; Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup. Alzheimers Dement (2011),7,280-292

4. Sperling R.A.; Jack C.R.; Aisen P.S.; Testing the right target and right drug at the right stage. Sci Transl Med (2011),3(111),111-133

5. Vellas B; Bateman R; Blennow K; Frisoni G; Johnson K; Katz R; Endpoints for Pre-Dementia AD Trials A Report from the EU/US/CTAD Task Force (2015),2(2),128-35

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First Steps Toward the French Validation of the Memory Binding Test (fMBT): Adaptation, Convergent Validity and Application to Normal Aging;L’Année psychologique;2023-09-27

2. An evaluation on changes in hippocampus size for cognitively normal, mild cognitive impairment, and Alzheimer’s disease patients using fuzzy membership function;Innovations in Systems and Software Engineering;2023-07-05

3. Cognitive and Neuropsychiatric Features of Idiopathic Normal Pressure Hydrocephalus;Normal Pressure Hydrocephalus;2023

4. Contribution of Memory Tests to Early Identification of Conversion from Amnestic Mild Cognitive Impairment to Dementia;Journal of Alzheimer's Disease;2022-08-16

5. Memory Binding Test and Its Associations With Hippocampal Volume Across the Cognitive Continuum Preceding Dementia;Assessment;2022-01-13